|Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study|
LA Carey, CM Perou, CA Livasy, LG Dressler, D Cowan, K Conway, ...
Jama 295 (21), 2492-2502, 2006
|Supervised risk predictor of breast cancer based on intrinsic subtypes|
JS Parker, M Mullins, MCU Cheang, S Leung, D Voduc, T Vickery, ...
Journal of clinical oncology 27 (8), 1160, 2009
|Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma|
TO Nielsen, FD Hsu, K Jensen, M Cheang, G Karaca, Z Hu, ...
Clinical cancer research 10 (16), 5367-5374, 2004
|Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer|
MCU Cheang, SK Chia, D Voduc, D Gao, S Leung, J Snider, M Watson, ...
JNCI: Journal of the National Cancer Institute 101 (10), 736-750, 2009
|Metastatic behavior of breast cancer subtypes|
H Kennecke, R Yerushalmi, R Woods, MCU Cheang, D Voduc, ...
Journal of clinical oncology 28 (20), 3271-3277, 2010
|Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group|
M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ...
Journal of the National cancer Institute 103 (22), 1656-1664, 2011
|Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype|
MCU Cheang, D Voduc, C Bajdik, S Leung, S McKinney, SK Chia, ...
Clinical cancer research 14 (5), 1368-1376, 2008
|Breast cancer subtypes and the risk of local and regional relapse|
KD Voduc, MCU Cheang, S Tyldesley, K Gelmon, TO Nielsen, ...
Journal of clinical oncology 28 (10), 1684-1691, 2010
|The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014|
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ...
Annals of oncology 26 (2), 259-271, 2015
|Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 …|
FM Blows, KE Driver, MK Schmidt, A Broeks, FE Van Leeuwen, ...
PLoS med 7 (5), e1000279, 2010
|The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status|
RB West, CL Corless, X Chen, BP Rubin, S Subramanian, K Montgomery, ...
The American journal of pathology 165 (1), 107-113, 2004
|A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor–positive breast cancer|
TO Nielsen, JS Parker, S Leung, D Voduc, M Ebbert, T Vickery, SR Davies, ...
Clinical cancer research 16 (21), 5222-5232, 2010
|Molecular characterisation of soft tissue tumours: a gene expression study|
TO Nielsen, RB West, SC Linn, O Alter, MA Knowling, JX O'Connell, S Zhu, ...
The Lancet 359 (9314), 1301-1307, 2002
|Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial|
J Hugh, J Hanson, MCU Cheang, TO Nielsen, CM Perou, C Dumontet, ...
Journal of clinical oncology 27 (8), 1168, 2009
|Prognostic significance of progesterone receptor–positive tumor cells within immunohistochemically defined luminal A breast cancer|
A Prat, MCU Cheang, M Martín, JS Parker, E Carrasco, R Caballero, ...
Journal of clinical oncology 31 (2), 203, 2013
|A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors|
I Espinosa, CH Lee, MK Kim, BT Rouse, S Subramanian, K Montgomery, ...
The American journal of surgical pathology 32 (2), 210-218, 2008
|Use of immunohistochemical markers can refine prognosis in triple negative breast cancer|
M Tischkowitz, JS Brunet, LR Bégin, DG Huntsman, MCU Cheang, ...
BMC cancer 7 (1), 134, 2007
|Systematic analysis of breast cancer morphology uncovers stromal features associated with survival|
AH Beck, AR Sangoi, S Leung, RJ Marinelli, TO Nielsen, ...
Science translational medicine 3 (108), 108ra113-108ra113, 2011
|deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data|
A McPherson, F Hormozdiari, A Zayed, R Giuliany, G Ha, MGF Sun, ...
PLoS Comput Biol 7 (5), e1001138, 2011
|EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer|
L Hughes-Davies, D Huntsman, M Ruas, F Fuks, J Bye, SF Chin, J Milner, ...
Cell 115 (5), 523-535, 2003